(Q37573895)

21 August 2017

0 references

1 reference

title

Is there a role for statins in atrial fibrillation? (English)

1 reference

21 August 2017

0 references

David E Dawe

1

1 reference

PubMed ID

19659628

21 August 2017

Vignendra Ariyarajah

series ordinal

2

1 reference

PubMed ID

19659628

21 August 2017

Aliasghar Khadem

series ordinal

3

1 reference

21 August 2017

1 August 2009

1 reference

Pacing and Clinical Electrophysiology

21 August 2017

1 reference

21 August 2017

32

1 reference

21 August 2017

1063-1072

1 reference

21 August 2017

8

1 reference

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Do statins have an antiarrhythmic activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

The effect of statin therapy on ventricular late potentials in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Perioperative atrial tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Is atrial fibrillation an inflammatory disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Electrical remodelling of chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

New ideas about atrial fibrillation 50 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Atrial extracellular matrix remodelling in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Electrical, contractile and structural remodeling during atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: report of three cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Circumferential pulmonary-vein ablation for chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Inflammation as a risk factor for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Histological substrate of atrial biopsies in patients with lone atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Effect of C-reactive protein reduction on paroxysmal atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Direct evidence of leukocyte adhesion in arterioles by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Inflammation and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Renin-angiotensin system gene polymorphisms and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Nitric oxide regulates the calcium current in isolated human atrial myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Statins and polyunsaturated fatty acids for treatment of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Treatment and prevention of atrial fibrillation with non-antiarrhythmic pharmacologic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Statin use and recurrence of atrial fibrillation after successful cardioversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Association of statin therapy and the risk of atrial fibrillation in patients with a permanent pacemaker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2009.02440.X

10.1111/J.1540-8159.2009.02440.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19659628